Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ion Channel Gating | 21 | 2021 | 323 | 3.600 |
Why?
|
Potassium Channels, Voltage-Gated | 13 | 2023 | 122 | 2.210 |
Why?
|
Potassium | 8 | 2021 | 281 | 2.030 |
Why?
|
Potassium Channel Blockers | 7 | 2023 | 64 | 1.690 |
Why?
|
Potassium Channels | 4 | 2023 | 340 | 1.430 |
Why?
|
Shab Potassium Channels | 8 | 2020 | 29 | 1.360 |
Why?
|
KCNQ1 Potassium Channel | 8 | 2023 | 16 | 1.350 |
Why?
|
Shaker Superfamily of Potassium Channels | 6 | 2016 | 49 | 1.200 |
Why?
|
Membrane Potentials | 12 | 2021 | 435 | 1.160 |
Why?
|
Myocytes, Cardiac | 3 | 2022 | 275 | 0.890 |
Why?
|
Shaw Potassium Channels | 3 | 2016 | 8 | 0.820 |
Why?
|
4-Aminopyridine | 3 | 2015 | 32 | 0.720 |
Why?
|
Patch-Clamp Techniques | 8 | 2021 | 396 | 0.670 |
Why?
|
Long QT Syndrome | 2 | 2023 | 34 | 0.580 |
Why?
|
Oocytes | 2 | 2020 | 220 | 0.560 |
Why?
|
Protein Subunits | 5 | 2015 | 122 | 0.540 |
Why?
|
Kinetics | 12 | 2015 | 1513 | 0.530 |
Why?
|
Antibodies | 2 | 2020 | 349 | 0.530 |
Why?
|
Ciguatoxins | 4 | 2016 | 4 | 0.490 |
Why?
|
Action Potentials | 3 | 2022 | 573 | 0.480 |
Why?
|
Kv1.2 Potassium Channel | 1 | 2012 | 22 | 0.440 |
Why?
|
Mutation | 9 | 2018 | 3952 | 0.430 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2021 | 86 | 0.410 |
Why?
|
Models, Molecular | 7 | 2021 | 1284 | 0.410 |
Why?
|
Kv1.5 Potassium Channel | 2 | 2008 | 12 | 0.390 |
Why?
|
Protein Conformation | 6 | 2018 | 881 | 0.370 |
Why?
|
HEK293 Cells | 6 | 2021 | 615 | 0.370 |
Why?
|
Animals | 25 | 2023 | 26518 | 0.370 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2022 | 101 | 0.370 |
Why?
|
Cricetulus | 6 | 2023 | 126 | 0.360 |
Why?
|
Genes, Dominant | 1 | 2009 | 117 | 0.360 |
Why?
|
Biophysics | 1 | 2009 | 152 | 0.350 |
Why?
|
Energy Transfer | 1 | 2008 | 25 | 0.340 |
Why?
|
Protein Structure, Tertiary | 6 | 2014 | 736 | 0.320 |
Why?
|
Xenopus | 4 | 2020 | 125 | 0.320 |
Why?
|
Models, Biological | 4 | 2011 | 1748 | 0.310 |
Why?
|
Ether-A-Go-Go Potassium Channels | 3 | 2015 | 26 | 0.310 |
Why?
|
CHO Cells | 5 | 2021 | 187 | 0.300 |
Why?
|
Cell Line | 8 | 2020 | 2466 | 0.300 |
Why?
|
Cricetinae | 5 | 2023 | 560 | 0.290 |
Why?
|
Amino Acid Sequence | 8 | 2016 | 2062 | 0.290 |
Why?
|
Structure-Activity Relationship | 6 | 2023 | 408 | 0.280 |
Why?
|
Mutation, Missense | 2 | 2021 | 276 | 0.280 |
Why?
|
Proline | 2 | 2015 | 57 | 0.270 |
Why?
|
Thiophenes | 1 | 2023 | 48 | 0.230 |
Why?
|
Humans | 27 | 2023 | 86281 | 0.220 |
Why?
|
Alanine | 2 | 2018 | 85 | 0.220 |
Why?
|
beta-Alanine | 1 | 2021 | 6 | 0.210 |
Why?
|
Giant Cells | 1 | 2021 | 19 | 0.210 |
Why?
|
Biotransformation | 1 | 2021 | 50 | 0.210 |
Why?
|
Microsomes, Liver | 1 | 2021 | 49 | 0.210 |
Why?
|
Desmoglein 2 | 1 | 2021 | 1 | 0.210 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 2 | 2012 | 10 | 0.210 |
Why?
|
Andersen Syndrome | 1 | 2021 | 1 | 0.210 |
Why?
|
Organogenesis | 1 | 2021 | 41 | 0.200 |
Why?
|
Larva | 1 | 2021 | 117 | 0.200 |
Why?
|
Death, Sudden, Cardiac | 1 | 2021 | 45 | 0.200 |
Why?
|
Brugada Syndrome | 1 | 2021 | 14 | 0.200 |
Why?
|
Loss of Function Mutation | 1 | 2021 | 42 | 0.200 |
Why?
|
Embryonic Development | 1 | 2021 | 73 | 0.200 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 484 | 0.200 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 114 | 0.190 |
Why?
|
Anticonvulsants | 1 | 2021 | 126 | 0.190 |
Why?
|
Embryo, Nonmammalian | 1 | 2021 | 192 | 0.190 |
Why?
|
Models, Cardiovascular | 1 | 2021 | 98 | 0.190 |
Why?
|
Protein Multimerization | 3 | 2021 | 172 | 0.190 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2021 | 118 | 0.190 |
Why?
|
Interleukin-6 | 1 | 2021 | 255 | 0.190 |
Why?
|
Molecular Sequence Data | 6 | 2014 | 3029 | 0.190 |
Why?
|
Electrophysiology | 4 | 2011 | 401 | 0.180 |
Why?
|
Arrhythmias, Cardiac | 1 | 2021 | 187 | 0.180 |
Why?
|
Binding Sites | 6 | 2016 | 1098 | 0.180 |
Why?
|
Mice | 9 | 2021 | 11313 | 0.180 |
Why?
|
Amino Acid Motifs | 3 | 2015 | 116 | 0.170 |
Why?
|
Threonine | 1 | 2018 | 33 | 0.160 |
Why?
|
NF-kappa B | 1 | 2021 | 442 | 0.160 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2008 | 279 | 0.160 |
Why?
|
Allosteric Regulation | 1 | 2018 | 68 | 0.160 |
Why?
|
Immunosuppressive Agents | 1 | 2023 | 977 | 0.160 |
Why?
|
Amino Acid Substitution | 3 | 2008 | 339 | 0.150 |
Why?
|
1-Butanol | 1 | 2016 | 3 | 0.150 |
Why?
|
Camelus | 1 | 2016 | 5 | 0.140 |
Why?
|
Alcohols | 1 | 2015 | 14 | 0.140 |
Why?
|
Microscopy, Confocal | 2 | 2009 | 268 | 0.140 |
Why?
|
Immunization | 1 | 2016 | 158 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 503 | 0.140 |
Why?
|
Antibody Formation | 1 | 2016 | 171 | 0.140 |
Why?
|
Markov Chains | 1 | 2015 | 125 | 0.130 |
Why?
|
Neurons | 2 | 2015 | 1545 | 0.130 |
Why?
|
Transfection | 3 | 2015 | 895 | 0.120 |
Why?
|
Mutagenesis | 2 | 2010 | 199 | 0.120 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2012 | 51 | 0.110 |
Why?
|
Genes, Reporter | 1 | 2012 | 266 | 0.110 |
Why?
|
Bacterial Proteins | 1 | 2018 | 861 | 0.100 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 272 | 0.100 |
Why?
|
Sequence Homology, Amino Acid | 3 | 2009 | 416 | 0.100 |
Why?
|
Protein Structure, Secondary | 2 | 2008 | 329 | 0.100 |
Why?
|
Electric Conductivity | 1 | 2010 | 144 | 0.100 |
Why?
|
Recombinant Proteins | 2 | 2020 | 1014 | 0.090 |
Why?
|
Molecular Dynamics Simulation | 1 | 2012 | 244 | 0.090 |
Why?
|
Protein Binding | 3 | 2015 | 1454 | 0.090 |
Why?
|
Marine Toxins | 1 | 2009 | 7 | 0.090 |
Why?
|
Molecular Biology | 1 | 2009 | 89 | 0.090 |
Why?
|
COS Cells | 3 | 2012 | 166 | 0.070 |
Why?
|
Kidney | 2 | 2011 | 1240 | 0.070 |
Why?
|
Electromagnetic Fields | 1 | 2006 | 26 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 1381 | 0.070 |
Why?
|
Protein Folding | 1 | 2008 | 280 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 1958 | 0.070 |
Why?
|
Fibroblasts | 2 | 2020 | 729 | 0.060 |
Why?
|
Computer Simulation | 1 | 2008 | 1077 | 0.060 |
Why?
|
Glycine | 1 | 2003 | 90 | 0.060 |
Why?
|
Jervell-Lange Nielsen Syndrome | 1 | 2023 | 1 | 0.060 |
Why?
|
Belgium | 1 | 2023 | 2 | 0.060 |
Why?
|
Luminescent Proteins | 1 | 2003 | 144 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2003 | 305 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 1917 | 0.050 |
Why?
|
Estrenes | 1 | 2021 | 8 | 0.050 |
Why?
|
Pyrrolidinones | 1 | 2021 | 16 | 0.050 |
Why?
|
Teratogens | 1 | 2021 | 13 | 0.050 |
Why?
|
Electrophysiological Phenomena | 1 | 2022 | 49 | 0.050 |
Why?
|
Peptides, Cyclic | 1 | 2021 | 43 | 0.050 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 555 | 0.050 |
Why?
|
Protein Structure, Quaternary | 1 | 2021 | 99 | 0.050 |
Why?
|
Mammals | 1 | 2023 | 227 | 0.050 |
Why?
|
Rabbits | 1 | 2021 | 636 | 0.050 |
Why?
|
HeLa Cells | 1 | 2021 | 498 | 0.050 |
Why?
|
Photobleaching | 1 | 2020 | 8 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2020 | 137 | 0.050 |
Why?
|
Phenotype | 2 | 2021 | 2375 | 0.040 |
Why?
|
Alleles | 1 | 2023 | 1127 | 0.040 |
Why?
|
Zebrafish | 1 | 2021 | 307 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 153 | 0.040 |
Why?
|
ERG1 Potassium Channel | 2 | 2010 | 14 | 0.040 |
Why?
|
Heart Rate | 1 | 2021 | 492 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2021 | 1214 | 0.040 |
Why?
|
Male | 2 | 2021 | 40860 | 0.040 |
Why?
|
Evolution, Molecular | 1 | 2003 | 813 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2023 | 1195 | 0.040 |
Why?
|
Mutant Chimeric Proteins | 1 | 2016 | 10 | 0.040 |
Why?
|
Hexanols | 1 | 2015 | 1 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2022 | 1456 | 0.030 |
Why?
|
Rats | 1 | 2021 | 3984 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2011 | 2810 | 0.030 |
Why?
|
Permeability | 1 | 2013 | 133 | 0.030 |
Why?
|
Electricity | 1 | 2012 | 23 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 2267 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 153 | 0.030 |
Why?
|
Signal Transduction | 1 | 2021 | 3233 | 0.020 |
Why?
|
Porosity | 1 | 2010 | 60 | 0.020 |
Why?
|
Polylysine | 1 | 2010 | 33 | 0.020 |
Why?
|
Protein Stability | 1 | 2010 | 99 | 0.020 |
Why?
|
Lysine | 1 | 2011 | 147 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 877 | 0.020 |
Why?
|
Child | 1 | 2021 | 6913 | 0.020 |
Why?
|
Magnesium | 1 | 2010 | 177 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 347 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2009 | 134 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 94 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 314 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2009 | 210 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2010 | 460 | 0.020 |
Why?
|
Cell Membrane | 1 | 2010 | 664 | 0.020 |
Why?
|
Static Electricity | 1 | 2006 | 89 | 0.020 |
Why?
|
Middle Aged | 1 | 2021 | 24957 | 0.010 |
Why?
|
Female | 1 | 2021 | 44405 | 0.010 |
Why?
|